Transvaginal mesh treatments for stress urinary incontinence (SUI) have been linked with higher rates of adverse events and complications by the United States Food and Drug Administration. SUI is most common among women who have had their pelvic muscles and tissue weakened through childbirth, and results in involuntary urine loss during common activities. Many women report leakage when doing everyday activities like exercise, or even sneezing/laughing. Ethicon’s Gynecare TVT Abbrevo is a surgical mesh option for SUI treatment; unfortunately any surgical mesh inserted transvaginally carries with it higher risks of complications, including the TVT Abbrevo Continence System.
According to analysis conducted by the United States FDA, transvaginal mesh bladder slings (including Ethicon Gynecare TVT Abbrevo) are associated with serious complications. Furthermore, it is not clear whether any additional benefits come with these elevated mesh risks. The most frequently reported TVT complication is mesh erosion (also called protrusion, exposure, and protrusion). Treatment of Gynecare TVT Abbrevo erosion requires a second surgery, and sometimes multiple revision surgeries cannot even fully remedy the problem. Treatment for the removal of mesh requires expensive hospitalization, surgical procedures, and possibly IV therapy and blood transfusions. Many patients were not fully warned of these potential complications prior to treatment, and file Gynecare lawsuit claims to help with medical expenses.
As early as October of 2008, the FDA was already warning healthcare practitioners about the complications linked with transvaginal mesh used to treat stress urinary incontinence. The warnings stemmed from higher reports of adverse events in patient who had received treatment with such devices, including Johnson & Johnson’s Ethicon Gynecare TVT Abbrevo Continence System. In the years since this initial warning, additional FDA communications have been made regarding transvaginal mesh complications, and it has been determined that mesh erosion and other adverse events are “not rare.” Often times, revision surgery and hospitalization are necessary in order to treat patients who suffer from mesh complications and side effects. Gynecare lawsuits are one option for helping patients pay for such expensive treatment and care.
If you were treated with Gynecare TVT and experienced complications, call the Willis Law Firm today. You may be eligible for significant financial compensation through a transvaginal mesh lawsuit. Currently our firm is reviewing potential cases nationwide for mesh products made by the following manufacturers:
Call us today to have your claim reviewed by a top Texas trial lawyer. All mesh lawsuit clients are taken on a contingency fee basis; you are not responsible for any fees unless a recovery is made.